Breakthroughs in understanding the epigenetic mechanisms involved in neurodegenerative disease have highlighted "epidrugs" as a potential avenue for therapeutic development. Here, we expand on the future of epidrugs against neurodegeneration and discuss promising novel targets underexploited thus far: histone kinases.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844958 | PMC |
http://dx.doi.org/10.1021/acsptsci.1c00265 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!